Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2010
08/04/2010EP2213663A1 Preparation of halogenated N-heteroaromatic polyhalogen derivatives
08/04/2010EP2213281A1 Pharmaceutical composition comprising N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/04/2010EP2212298A1 Deuterated etravirine
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/04/2010CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
08/04/2010CN101795566A Co-crystals of pyrimethanil and dithianon
08/04/2010CN101792440A Quinazolinone derivatives, preparation and application thereof
08/04/2010CN101792420A Preparation of halogenated n-heteroaromatic polyhalogen derivatives
08/04/2010CN101130542B Synthesis method of antiviral nucleoside analogue
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767680 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010US7767624 3-Heterocyclyl substituted benzoic acid derivatives
08/03/2010US7767623 agricultural fungicides; silane or silanol substituted hetero(thio)carbonylaminobenzene compounds; corresponding anilino intermediates
07/2010
07/29/2010WO2010085128A2 Processes for preparing hiv reverse transcriptase inhibitors
07/29/2010WO2010084050A2 Quinazolinone derivatives useful as vanilloid antagonists
07/29/2010WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
07/29/2010US20100190983 Process for preparing voriconazole
07/29/2010US20100190982 Process for the preparation of lamivudine form i
07/29/2010US20100190977 4-phenylamino-quinazolin-6-yl-amides
07/29/2010US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis
07/29/2010US20100190803 Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient
07/29/2010US20100190746 Quinazolinones as potassium channel modulators
07/29/2010US20100189796 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
07/29/2010US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
07/29/2010US20100188618 Liquid-crystal display
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/29/2010CA2749529A1 Quinazolinone derivatives useful as vanilloid antagonists
07/28/2010EP2210892A2 Neurologically-active compounds
07/28/2010EP2210880A1 Benzoxazinone derivative
07/28/2010EP2210879A1 Pyrimidine derivatives and use thereof for combating undesired plant growth
07/28/2010EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists
07/28/2010EP2209761A1 Diphenyl substituted cycloalkanes
07/28/2010EP2209390A1 Complex product with advanced assimilation efficacy for humans and its utilization
07/28/2010EP1971579B1 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
07/28/2010EP1369418B1 Quinazoline derivatives
07/28/2010CN1845907B Guanidine derivatives
07/28/2010CN101790519A 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
07/28/2010CN101790518A Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
07/28/2010CN101787019A Quinazoline derivatives
07/28/2010CN101787017A Optical pure quinazoline compound
07/28/2010CN101786997A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
07/28/2010CN101786996A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
07/28/2010CN101786991A Substituted tetracycline compounds
07/27/2010US7763632 administering drugs succh as N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl) carbonyloxy}phenylalanine, for the treament asthma, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, graft versus host disease and arthritis
07/27/2010US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans
07/27/2010US7763628 Quinazolinones useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity; N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide monomethanesulfonate
07/27/2010US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/27/2010CA2631535C Spirocyclic quinazoline derivatives as pde7 inhibitors
07/27/2010CA2546701C Crystalline ammonium salts of rosuvastatin
07/27/2010CA2436659C Cannabinoid receptor ligands
07/22/2010WO2010083241A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/22/2010WO2010082072A1 Process for the preparation of rosuvastatin salts
07/22/2010WO2010081861A1 Process for the preparation of rosuvastatin
07/22/2010WO2010045379A3 Pyridine non-classical cannabinoid compounds and related methods of use
07/22/2010WO2009157014A3 A process for preparing hmg-coa reductase inhibitors and intermediates
07/22/2010US20100184979 New process for preparing 2-(3--phenyl)-2-methylproprionic acid
07/22/2010US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines
07/22/2010US20100184974 Protease Inhibitors
07/22/2010US20100184789 Inhibitors of protein kinases
07/22/2010US20100184788 Heterocyclic derivatives
07/22/2010US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
07/22/2010US20100184786 Polar Quinazolines
07/22/2010US20100184780 Inhibitors of protein kinases
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183606 Monocyclic heterocycles as kinase inhibitors
07/22/2010US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material
07/22/2010CA2749727A1 Process for the preparation of rosuvastatin salts
07/22/2010CA2749157A1 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
07/21/2010EP2207876A1 Stereo-specific hydroxylation
07/21/2010EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
07/21/2010CN1964954B Pyrazolo pyrimidines
07/21/2010CN1960977B Quinazoline derivative
07/21/2010CN1954446B 有机电致发光元件 Organic electroluminescent element
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN1751031B HIV replication inhibiting pyrimidines
07/21/2010CN101784532A Novel HIV reverse transcriptase inhibitors
07/21/2010CN101784531A 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
07/21/2010CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
07/21/2010CN101784276A Use of compounds for preparing anti-tuberculosis agents
07/21/2010CN101781273A dipeptidylpeptidase iv inhibitor containing guanidyl
07/21/2010CN101781265A Conjugate of amino acid and pesticide and preparation method thereof and application thereof as pesticide
07/21/2010CN101781259A Precursor compound of 18F marked tumor inhibitor Monastrol as well as preparation method and application
07/21/2010CN101781258A Dihydro pyrimidone sulfoacid as well as salt compound and preparation method thereof
07/21/2010CN101041635B Method for synthesizing ketenes amine condensation derivatives
07/20/2010US7759487 such as 1-(2,4-dimethylpyrimidine-5-carbonyl)-4-piperidone; useful as intermediates for preparation of antagonists of chemokine receptor (CCR5), for the treatment of HIV and AIDS
07/20/2010US7759486 2,4,5-Trisubstituted pyrimidine compounds
07/20/2010US7759379 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
07/20/2010US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis
07/20/2010US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease
07/20/2010US7759353 Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
07/20/2010US7759350 Pyrimidine carboxamides
07/20/2010US7759345 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma
07/20/2010US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid
07/20/2010US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 427